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Abstract: During an apnea, hemodynamic complications such as hypoxemia, a rise 
in systemic and pulmonary arterial pressure, and changes in heart rate occur in 
patients with obstructive sleep apnea (OSA). Potential mechanisms of OSA-
associated renal dysfunction include renal hypoxia, hypertension, endothelial 
dysfunction. Hypertension is common in patients with OSA. This study aims to assess 
OSA patients' renal functions and investigate the creatinine clearance (CC) values 
across OSA patients with and without hypertension. The study included 530 
individuals with OSA and 60 individuals with an apnea-hypopnea index (AHI) of <5. 
CC was calculated with the Cockcroft-Gault Equation. Patients with OSA were divided 
into two groups as the group of patients with hypertension (HT) (group 1) and without 
HT (group 2). The study included 339 (64%) male and 191 (36%) female patients. It 
was found that 32.4% of OSA patients had HT (Group 1). There was a significant 
difference in CC and urea levels between groups 1 and 2 (p<0.001; p=0.005). While 
CC was low in the OSA group, CC values were not statistically significantly different 
between the OSA patients and the control group (p>0.05). A statistically significant 
difference was detected in urea and creatinine levels between the OSA and control 
groups (p=0.005; p=0.012). Creatinine clearance decreases in patients with OSA in 
the presence of HT. Patients with OSA often experience cardiovascular disorders, and 
glomerular endothelial dysfunction occurs in OSA patients. 
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INTRODUCTION 
Obstructive sleep apnea (OSA) is the most common sleep-related breathing disorder 
(Schwab RJ et al., 1998). OSA results from collapses of the upper airway leading to 
recurrent interruptions of breathing during sleep. Breathing can be interrupted by 
complete or partial obstructions in the upper airway (Lindberg E et al., 2000). The 
disorder is characterized by snoring, excessive daytime sleepiness, and apnea. In the 
literature, the reported prevalence of obstructive sleep apnea in the population varies 
from 0.3% to 15% affecting approximately 1-5% of adults (Koktürk O et al., 1997). 
During apneas, hemodynamic complications such as hypoxemia, a rise in systemic 
and pulmonary arterial pressure, and changes in heart rate occur in patients with OSA. 
As a result, emerging cardiac risks are high. The significant complications arising in 
patients with OSA reports associated with the cardiovascular system. 
 Systemic arterial hypertension accounts for 30-40% of such complications 
(James M et al., 2004; Shahar E et al., 2001). The severity of hypertension finds out 
to correlate to the severity of OSA in such patients. Furthermore, studies have shown 
that 22-30% of patients diagnosed with idiopathic hypertension have OSA concurrently 
(Lavie P et al.,1984). It’s known that the pathophysiology of the relationship is not clear 
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enough. The relationship between OSA and the cardiovascular system has been 
associated with increased sympathetic nerve traffic, vagal activity, insulin resistance. 
In one study, albumin excretion was associated with cardiovascular events, and it 
interpreted as an indicator of endothelial dysfunction (Faulx M et al., 2007). 
Limitation of this study was obesity and hypertension. In the study of Inal BB et 
al., 2009, CC was lower in OSA patients with HT than in OSA patients without HT. 
However, OSA patients were not classified according to OSA severity, and the study 
sample was too small. Our study aimed to evaluate the renal function of OSA patients 
by assessing the value of creatinine clearance (CC) of OSA patients with and without 
hypertension. 
 
MATERIALS AND METHOD 
 A total of 590 people; who had undergone polysomnography (PSG) in Kartal 
Dr. Lutfi Kirdar Training and Research Hospital were evaluated retrospectively. The 
study included 530 individuals with OSA and 60 individuals with an apnea-hypopnea 
index (AHI) of < 5 as a control group. Patients diagnosed with diabetes, rheumatic 
diseases, acute and or chronic renal failure, or nephropathy were excluded from the 
study. Age, body weight, height, gender, apnea index(AI), oxygen desaturation index 
(ODI) of patients, and oxygen saturation values of <90 (TS90%) were recorded from 
the medical files. CC was calculated using the Cockcroft-Gault equation as follows: 
CC = (140-age) ( ideal weight)/Serum creatinine (mg/dl) X72. For women, the value 
were adjusted by multiplying the results by 0.85. Video images and PSG recordings 
of patients taken for the entire night were obtained to diagnose obstructive sleep 
apnea.  
 Apneas measured by a thermal sensor and described as a ≥90% reduction in 
the airflow signal for at least 10 seconds, with ≥90% of that period meeting the 
amplitude criterion. A prolonged and increased respiratory effort in the absence of 
airflow describes as obstructive apnea. Hypopnea was described as a decrease of 
≥30% in the nasal pressure signal compared to the baseline for at least 10 seconds, 
resulting in 3% desaturation or arousal compared to the baseline and meeting the 
amplitude criterion during ≥90% of the time. AHI values of 5-14.9 consider indicating 
mild OSA, AHI values of 15-29.9 considered to indicate moderate OSA, and AHI 
values of ≥30 considered severe OSA. Patients diagnosed with OSA divided into two 
groups as patients with and without hypertension, accounting for hypertension (HT) 
group (group 1) and the non-HT group (group 2), respectively. Patients in the HT group 
were previously diagnosed with HT and were taking antihypertensive medications. The 
study approved by an institutional ethics committee 
Statistical Analysis 
 For the statistical analysis of the results, SPSS 20.0 software was used. The 
Kolmogorov-Smirnov test uses to determine whether continuous variables conformed 
to a normal distribution. For continuous variables of normal distribution, the 
independent t-test uses to compare the means of two groups, and the one-way 
ANOVA was used to compare the means of more than two groups. Pearson's chi-
square test uses to assess the relationship between two continuous variables. For 
categorical variables, percentage and frequency values use as descriptive statistics. 
Mean and standard deviation was used to describe continuous variables. A p-value of 
less than 0.05 was considered statistically significant.   
 
RESULTS AND DISCUSSION 
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 The study included 530 OSA patients consisting of 339 (64%) men and 191 
(36%) women. In addition, 60 individuals were included in the study as the control 
group. The mean age was 49 ± 12 years. CC values were found see as 67.78 ± 27.4 
ml/min and 73.79 ± 25.3 ml/min in the OSA and control groups, respectively. CC was 
low in the OSA population, but there was no statistically significant difference in CC 
between the OSA and control groups (p> 0.05). Urea and creatinine levels were 
statistically significantly different between the OSA and control groups (p = 0.005; p = 
0.012, respectively). Age and gender were not different between the OSA group and 
the control group (p> 0.05). The demographic characteristics of patients were shown 
in table 1. In the OSA group, a statistically significant but weak correlation of CC was 
found in the same direction with AHI, AI, and minimum saturation (p: 0.032, r: 0.093; 
p: 0.003, r: 0.130; p: 0.009, r: 0.113).  
 When the patients were stratified by OSA severity, there were no significant 
differences in CC between the mild-moderate and severe OSA patients (p> 0.05). In 
our study, we found out that 32.4% of OSA patients had concomitant HT. CC and urea 
levels were significantly different between groups 1 and 2 (p<0.001) (Figure 1). Body 
mass index (BMI) was not significantly different between groups 1 and 2. When AHI, 
AI, and ODI compare between group 1 and group 2, no significant differences were 
observed (p> 0.05) (Table 2). 
          
Table 1. Demographic Characteristics of OSA and Control Patients 
  
OSA Control p value 
Male/Female 339/191  38/22  0,328 
Age( years) 49±12  48±11  0,614  
Urea (mg/dl) 33,6±10,8  29,5±8  0,005 
Creatinine Clearance (ml/dk) 67,78±27,4  73,79±25,3  0,392 
Body mass index (kg/m²) 31,63±5,54 30,66±4,21 0,491 
Apnea hypopnea index 32,21±21,36  3,4±2,1  <0,001 
 
 
Table 2. Demographic Characteristics of OSA Patients with and without Hypertension 
  OSA HT+ OSA HT - p value 
Male/Female 92/80 247/111 0,086 
Age( years) 51±10 46±11 0,079  
Urea (mg/dl) 35,81±13,51 32,56±9,01  0,005 
Creatinine Clearance (ml/dk) 58,03±25,63  69,50±27,55  0,005 
Body mass index (kg/m²) 32,66±5,33 31,14±5,58 0,297 
Apnea hyponea index 33,42±23,24  32,21±26,96  0,596 
Apnea index 18,10±17,14  18,21±16,54  0,398 
Oxygen desaturation index 25,01±24,12 26,17±12,66 0,172 
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Figure 1. Creatinine Clearance in OSA Patients with and without Hypertension 
 
 OSA, generally characterized by hypoxemia resulting from recurrently 
obstructed upper airways during sleep. There is a strong relationship between OSA 
and cardiovascular diseases. Of cardiovascular disorders, HT occurs at a rate of 30-
40% in OSA patients (Shahar E et al., 2001)). Similarly, we found out that the 
frequency of HT in OSA patients was 32.4% in our study. When we compared the CC 
and urea levels in OSA patients between the HT and non-HT groups in our study, we 
found out that the HT group had significantly lower CC and urea levels compared to 
the non-HT group. This situation indicates that patients; who suffer from sleep apnea 
have cardiovascular issues contributing to glomerular endothelial dysfunction. Faulx 
et al. conducted a study on 496 OSA patients to evaluate OSA severity, GFR, and 
albumin excretion. They found out that albumin excretion was higher in patients with 
severe OSA. When patients were grouped by OSA severity, GFR was normal in all 
groups (Faulx M et al., 2007). Similarly, CC was not found to be different by OSA 
severity in our study. However, there was a significant difference in CC between the 
HT and non-HT groups.  
 In one study, 91 morbidly obese OSA patients were assessed for renal 
functions before bariatric surgery. OSA was found in 55 patients. Creatinine values in 
the group with OSA were observed to be  significantly higher than in patients without 
OSA (Agrawal V et al., 2009). In a study on 858 patients, the effects of nocturnal 
hypoxemia on renal functions investigate, and patients were followed up for an 
average of 2.1 years. Patients with OSA had a higher rate of deterioration in renal 
functions compared to the control group (Ahmed SB et al., 2011). Urinary albumin 
excretion was  higher in hypertensive patients with OSA than hypertensive patients 
without OSA (Tsioufis C et al., 2008). 
 In the study by Inal BB et al., CC was  72.3 ± 9.9 ml/min in OSA patients with 
HT and 84.33 ± 16.98 ml/min in OSA patients without HT. Between those two groups 
of patients, CC was statistically significantly different (İnal BB et al., 2009). Similarly, 
CC was  statistically significantly lower in the HT group than the non-HT group in our 
study. In a survey of 9000 OSA patients, chronic kidney disease was found in 30.5% 
of the study population (Iseki K et al., 2008). The mechanisms of OSA-related chronic 
renal failure have not been elucidated. The majority of studies indicate that 
hypertension, oxidative stress, endothelial dysfunction, and hypoxemia-related 
activation of the sympathetic nervous system and the renin-angiotensin-aldosterone 
system resulting from a sleep- related breathing disorder induce kidney damage or 
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chronic kidney disease indirectly (Adeseun GA et al., 2010; Abdel-Kader K et al., 2012; 
Di Murro A et al.,2010). 
 In a study on 634 OSA patients and 62 individuals in the control group, GFR 
was  lower in the group of OSA patients with metabolic compared to the OSA patients 
without metabolic (Uyar M et al.,2016). In a study on 93 OSA patients, patients group 
by OSA severity. That study found that CC values were not statistically significantly 
different between the patient and the control groups. Furthermore, OSA severity and 
CC were not correlated (Karakaş S et al.,2012). Hypertension and diabetes rank the 
first as the predisposing factors for chronic kidney failure. In OSA patients without 
hypertension or diabetes, it has been shown that increased sympathetic activity at 
night and endothelial dysfunction act as risk factors for developing chronic kidney 
disease (Mallamaci F et al.,2011). Although renal dysfunction in OSA patients 
considers the risk factors involved in the development of OSA, it is thought that 
pathophysiological effects of OSA such as hypoxemia, systemic inflammation, and 
oxidative stress could be involved in the development of renal dysfunction, too. A 
meta-analysis examining  different study designs  showed the importance of poor renal 
function in OSA patients (Hwu, DW et al., 2017).  
 Meta-analysis of 12 studies including 3344 people to investigate the 
relationship between eGFR and OSAS showed that the decrease of eGFR was  
related to moderate and severe OSAS, and the levels of eGFR decreased significantly 
in OSAS patients with hypertension and diabetes (Liu, T et al., 2021). A study on 27 
OSA patients evaluating renal functions reported that serum creatinine levels 
decreased and GFR rose from 72.9 mg/dl to 79.3 mg/dl after a three-month, short-
term continuous positive airway pressure (CPAP) therapy (Koga S et al.,2013). 
Another study found that the glomerular filtration rate improved with short-term CPAP 
therapy (Kinebuchi S et al., 2004). 
 The retrospective design, the impossibility to evaluate urinary albumin 
excretion of patients, and the inclusion of patients undergoing PSG in the control group 
can suggest the limitations of our study. 
 
CONCLUSION 
 This study aimed to evaluate the creatinine clearance (CC) values in OSA 
patients with and without hypertension. Creatinine clearance was lower in OSA 
patients with HT than in OSA patients without HT in our study. This condition can 
attribute to glomerular endothelial dysfunction. Kidney failure may remain 
asymptomatic as long as GFR does not drop to very low levels ( 30-50 ml/min). In light 
of these findings and the respective literature, it is critical to follow up with OSA patients 
for hypertension and kidney function in clinical practice. 
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